These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 38794219)

  • 1. Development and Validation of an LC-MS/MS Assay for the Quantitation of MO-OH-Nap Tropolone in Mouse Plasma: Application to In Vitro and In Vivo Pharmacokinetic Studies.
    Aldhafiri WN; Chhonker YS; Ahmed N; Singh SK; Haney SL; Ford JB; Holstein SA; Murry DJ
    Molecules; 2024 Sep; 29(18):. PubMed ID: 39339419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to Cysteamine Therapy Among Patients Diagnosed with Cystinosis in Saudi Arabia: A Prospective Cohort Study.
    Algasem R; Zainy N; Alsabban E; Almojalli H; Alhasan K; Ali T; Broering D; Aleid H
    Pharmacy (Basel); 2024 Aug; 12(4):. PubMed ID: 39195852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New and Rapid LC-MS/MS Method for the Determination of Cysteamine Plasma Levels in Cystinosis Patients.
    Simeoli R; Cairoli S; Greco M; Bellomo F; Mancini A; Rossi C; Dionisi Vici C; Emma F; Goffredo BM
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis.
    Armas D; Holt RJ; Confer NF; Checani GC; Obaidi M; Xie Y; Brannagan M
    Adv Ther; 2018 Feb; 35(2):199-209. PubMed ID: 29411268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis.
    Hector E; Cairns D; Michael Wall G
    Orphanet J Rare Dis; 2022 Jun; 17(1):231. PubMed ID: 35710564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term cysteamine treatment in patients with cystinosis.
    Ariceta G; Giordano V; Santos F
    Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery and therapeutic perspectives for proximal tubulopathies.
    Keller SA; Chen Z; Gaponova A; Korzinkin M; Berquez M; Luciani A
    Kidney Int; 2023 Dec; 104(6):1103-1112. PubMed ID: 37783447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients.
    Klank S; van Stein C; Grüneberg M; Ottolenghi C; Rauwolf KK; Grebe J; Reunert J; Harms E; Marquardt T
    Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. User-friendly and ultra-stable all-inclusive gold tablets for cysteamine detection.
    Al-Kassawneh M; Sadiq Z; Jahanshahi-Anbuhi S
    RSC Adv; 2023 Jun; 13(28):19638-19650. PubMed ID: 37397283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis.
    Franzin M; Rossetto S; Ruoso R; Del Savio R; Stocco G; Decorti G; Addobbati R
    Orphanet J Rare Dis; 2022 Nov; 17(1):400. PubMed ID: 36329442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDM Is Alive and Kicking!
    Lemaitre F; Hesselink DA
    Ther Drug Monit; 2023 Feb; 45(1):3-5. PubMed ID: 36127795
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomarkers in Nephropathic Cystinosis: Current and Future Perspectives.
    Emma F; Montini G; Pennesi M; Peruzzi L; Verrina E; Goffredo BM; Canalini F; Cassiman D; Rossi S; Levtchenko E
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.
    Emma F; Hoff WV; Hohenfellner K; Topaloglu R; Greco M; Ariceta G; Bettini C; Bockenhauer D; Veys K; Pape L; Hulton S; Collin S; Ozaltin F; Servais A; Deschênes G; Novo R; Bertholet-Thomas A; Oh J; Cornelissen E; Janssen M; Haffner D; Ravà L; Antignac C; Devuyst O; Niaudet P; Levtchenko E
    Kidney Int; 2021 Nov; 100(5):1112-1123. PubMed ID: 34237326
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.